{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T05:16:48Z","timestamp":1777526208299,"version":"3.51.4"},"reference-count":40,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["ASSAY and Drug Development Technologies"],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:p>Here, we briefly discuss 17 PCT patent applications related to drug repurposing that were published during the final quarter of 2024. As always, we have chosen the documents based on significance only, which gave us a wide range of applicants, active agents, and geographic representation. Applicants are not only from the United States and China but also from Japan, Germany, the United Kingdom, Canada, and even remote places such as Algeria and Iceland. Significantly, the contribution from Iceland is how to induce therapeutic hypothermia\u2014but with entacapone, used in Parkinson\u2019s disease. The UK company, HealX, presents data showing that Angelman syndrome, an intractable neurodevelopmental disorder, could be treated with the common NSAID sulindac. Gliclazide, an old antidiabetic, could potentially treat schizophrenia, as inventors from Chinese Ping An-Shionogi report. These are only a few highlights from the stream of documents that have been issued towards the end of 2024.<\/jats:p>","DOI":"10.1177\/1540658x251361263","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T20:28:22Z","timestamp":1758918502000},"page":"324-331","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Drug Repurposing Patent Applications October\u2013December 2024"],"prefix":"10.1177","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1491-6250","authenticated-orcid":false,"given":"Hermann A.M.","family":"Mucke","sequence":"first","affiliation":[{"name":"H.M. Pharma Consultancy, Wien, Austria."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2025,9]]},"reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/ceo.14043"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0198432"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-022-00728-0"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10121950"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA120.013716"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27767"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1080\/17425255.2017.1262843"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3861"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1515\/revneuro-2020-0001"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-017-0507-7"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1315788"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.122.060106"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.17075"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biochi.2023.04.003"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.30852"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.3390\/genes12070987"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2018.00476"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-1073"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11175221"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2014-307727"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2014.11.020"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2016.16060735"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1139\/y78-009"},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-020-00397-1"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-022-02847-x"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2023.04.017"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1128387"},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.5067.381"},{"key":"e_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/18.4.833"},{"key":"e_1_3_1_31_2","first-page":"79","article-title":"Focused arousal and the cognitive 40-Hz event-related potentials: Differential diagnosis of Alzheimer\u2019s disease","volume":"317","author":"Sheer DE","year":"1989","unstructured":"Sheer DE. Focused arousal and the cognitive 40-Hz event-related potentials: Differential diagnosis of Alzheimer\u2019s disease. Prog Clin Biol Res, 1989; 317:79\u201394.","journal-title":"Prog Clin Biol Res"},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1234"},{"key":"e_1_3_1_33_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA118.004673"},{"issue":"6","key":"e_1_3_1_34_2","first-page":"3481","article-title":"Palbociclib improves cardiac dysfunction in diabetic cardiomyopathy by regulating Rb phosphorylation","volume":"11","author":"Wang Z","year":"2019","unstructured":"Wang Z, , Li J, , Wang Y, et al. Palbociclib improves cardiac dysfunction in diabetic cardiomyopathy by regulating Rb phosphorylation. Am J Transl Res, 2019; 11(6):3481\u20133489.","journal-title":"Am J Transl Res"},{"key":"e_1_3_1_35_2","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2020.1781814"},{"key":"e_1_3_1_36_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdq344"},{"key":"e_1_3_1_37_2","doi-asserted-by":"publisher","DOI":"10.1038\/emboj.2011.70"},{"key":"e_1_3_1_38_2","doi-asserted-by":"publisher","DOI":"10.2337\/db16-1250"},{"key":"e_1_3_1_39_2","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol31100450"},{"key":"e_1_3_1_40_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28951"},{"key":"e_1_3_1_41_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI172802"}],"container-title":["ASSAY and Drug Development Technologies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1540658X251361263","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1540658X251361263","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1540658X251361263","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:28:56Z","timestamp":1777393736000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.1177\/1540658X251361263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["10.1177\/1540658X251361263"],"URL":"https:\/\/doi.org\/10.1177\/1540658x251361263","relation":{},"ISSN":["1540-658X","1557-8127"],"issn-type":[{"value":"1540-658X","type":"print"},{"value":"1557-8127","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9]]}}}